Also trades as: RADX (NASDAQ) · $vol 1M
RAD.AX ASX
Radiopharm Theranostics Limited
1W: +5.3%
1M: -4.8%
3M: -9.1%
YTD: -13.0%
1Y: -9.1%
3Y: -89.6%
A$0.02 ($0.01)
+0.00 (+5.00%)
Weekly Expected Move ±10.2%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market CapA$49.7M ($35.4M)
52W Range0.017-0.04
Volume393,037
Avg Volume2,870,002
Beta0.78
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORiccardo Canevari
Employees14
SectorHealthcare
IndustryBiotechnology
IPO Date2021-11-24
Websiteradiopharmtheranostics.com
62 Lygon Street
Carlton, VIC 3053
AU
Carlton, VIC 3053
AU
61 3 9824 5254
About Radiopharm Theranostics Limited
Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton, Australia.
Recent Insider Trades
No insider trades found